Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2008
12/18/2008WO2008130879A3 Tetrahydroindole and tetrahydroindazole derivatives
12/18/2008WO2008130320A3 Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
12/18/2008WO2008116139A3 N-heterocyclic compounds useful as inhibitors of janus kinases
12/18/2008WO2008100457A3 Functionally selective alpha2c adrenoreceptor agonists
12/18/2008WO2008080056A3 Pyridazinones and furan-containing compounds
12/18/2008WO2008013823A3 Co-crystals of (2r-trans)-6-chloro-5-[[4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]carbonyl]-n,n,1-trimethyl-alpha-oxo-1h-indole-3-acetamide
12/18/2008WO2007131016A3 Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
12/18/2008US20080312451 Process For the Preparation of Sartan Derivatives and Intermediates Useful in Such Process
12/18/2008US20080312438 -(2-Aminopyrid-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for immunoglobulins IgE and IgG antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis, multiple sclerosis
12/18/2008US20080312306 Polymorphs, solvates, and hydrate of 5-(4'-fluoro-2'-oxo-1',2'-dihydrospiro[cyclopropane-1,3'-indol]-5'-yl)-1-methyl-1h-pyrrole-2-carbonitrile
12/18/2008US20080312292 Antipruritics
12/18/2008US20080312287 Compound and Methods For the Treatment of Cancer and Malaria
12/18/2008US20080312248 Pyrimidinyl Aryl Urea Derivatives Being Fgf Inhibitors
12/18/2008US20080312240 Bicyclic Piperazines as Metabotropic Glutatmate Receptor Antagonists
12/18/2008US20080312238 4-Arylazo-3,5-Diamino-Pyrazole Compounds and Use Thereof
12/18/2008US20080312232 N-(3-fluoro-4-(6-(pyrrolidine-1-carboxamido)pyridin-4-yloxy)phenyl)-1-(2-hydroxy-2-methylpropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide, used for prophylaxis and treatment of hepatocyte growth factor mediated diseases, such as cancer and angiogenesis
12/18/2008US20080312217 N,N'-Bis-{4-[N'-(3,5-diamino-6-chloro-pyrazine-2-carbonyl)-guanidino]-butyl}terephthalamide, used for the treatment of conditions mediated by the blockade of an epithelial sodium channels
12/18/2008US20080312213 7-Pyrazolylbenzazepines Having Affinity For D3 Receptor
12/18/2008US20080312212 Organic Compounds
12/18/2008US20080312207 Compounds
12/18/2008US20080312192 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases
12/18/2008US20080311179 for treating disease or condition chosen from Parkinson's disease, Huntington's chorea, schizophrenia, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease, age related cognitive decline, sleep, eating disorders
12/18/2008US20080311079 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
12/18/2008US20080311077 Antiviral Compounds
12/18/2008US20080311076 Morpholinylanilinoquinazoline Derivatives For Use As Antiviral Agents
12/18/2008US20080309229 Arylamine Polymer
12/18/2008US20080308149 Squarylium dye, method of producing the same, photoelectric conversion element containing the dye, and solid-state imaging device
12/18/2008DE60224400T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure
12/18/2008CA2694860A1 Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
12/18/2008CA2690567A1 New compounds
12/18/2008CA2690080A1 Urotensin ii receptor antagonists
12/18/2008CA2689948A1 Gamma secretase modulators
12/18/2008CA2689667A1 Synthesis of substituted-3-aminopyrazoles
12/18/2008CA2689209A1 Piperazine compounds having herbicidal action
12/18/2008CA2689117A1 5-heteroaryl substituted indazoles as kinase inhibitors
12/18/2008CA2688343A1 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
12/18/2008CA2685402A1 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
12/18/2008CA2684886A1 Dual-acting benzoimidazole antihypertensive agents
12/17/2008EP2003119A1 Substituted acetamides as modulators of EP2 receptors
12/17/2008EP2003118A1 Cinnamic acid derivatives as modulators of EP2 receptors
12/17/2008EP2002837A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/17/2008EP2002834A1 Aryl and hetaryl amides as modulators of EP2 receptors
12/17/2008EP2001870A2 Kinase inhibitors
12/17/2008EP2001869A1 Process for producing biphenyl-tetrazole compounds
12/17/2008EP2001863A1 2-(cyclic amino)-pyrimidone derivatives as tpk1 inhibitors
12/17/2008EP2001855A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
12/17/2008EP2001849A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
12/17/2008EP2001480A2 Indazole compounds
12/17/2008EP2001298A2 Substituted 5-hetaryl-4-aminopyrimidines
12/17/2008EP1809607B1 Sulfonyl benzimidazole derivatives
12/17/2008EP1773763B1 Lysine based compounds
12/17/2008CN101326180A Piperazine derivative renin inhibitors
12/17/2008CN101326179A New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease
12/17/2008CN101326177A Dihydroisoindolones as allosteric modulators of glucokinase
12/17/2008CN101326176A Pyridazine compound and use thereof
12/17/2008CN101326167A Pyridiazinone derivatives for tumour treatment
12/17/2008CN101325953A 4-heteroaryl-pyrimidine derivatives and use thereof as protein kinase inhibitors
12/17/2008CN101323611A Polar sensitive fluorescent probe compounds for arginine residue marker, preparation and use thereof
12/17/2008CN101323610A Novel preparation of trityl group candesartan cilexetil intermediate
12/17/2008CN101323601A Triazole derivatives useful in therapy
12/17/2008CN100443481C Imidazolyl-cyclic acetals
12/17/2008CN100443474C New pyridazin-3(2h)-one derivatives
12/17/2008CN100443469C 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/16/2008US7465808 3-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-2-m-tolyl-propionic acid and Na salt; 3-[5-Benzo[1,3]dioxol-5-yl-1-(2,5-dichloro-phenyl)-1H-pyrazol-3-yl]-2-(3-chloro-phenyl)-acrylic acid; 5-{(S)-2-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-pyrazol-3-yl]-1-m-tolyl-ethyl}-1H-tetrazole
12/16/2008US7465750 Use of GAL3 antagonist for treatment of depression and/or anxiety and compounds useful in such methods
12/16/2008US7465744 Triazole compounds and the therapeutic use thereof
12/16/2008US7465735 crop protection agents for controlling harmful fungi; improved activity; 6-chloro-2-(N'-isopropylidene-hydrazino)-5-(2,4,6-trifluorophenyl)pyrimidine-4-yl]-((S)-1-trifluoromethylethyl)amine; against Septoria Leaf Blotch of Wheat, Net Blotch of Barley and Mildew of Cucumber
12/16/2008US7465732 (2S,4S)-4-(piperazin-1-yl)pyrrolidine-2-methanone derivatives
12/16/2008US7465731 HDAC inhibitor
12/16/2008US7465728 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity
12/16/2008US7465725 e.g. N-{2-[3-(3,4-dimethoxy-phenyl)-propyl]-6-morpholin-4-yl-pyrimidin-4-yl}-N'-(1H-indol-3-ylmethylene)-hydrazine; interleukin-12 antagonist; antiinflammatory, antidiabetic agent; rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis, or insulin-dependent diabetes mellitus
12/16/2008US7465718 Ansamycins having improved pharmacological and biological properties
12/16/2008CA2398887C 2,4,di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
12/11/2008WO2008150500A1 A process for preparing 5-bromo-3-[(r)-1-methyl-pyrrolidin-2-ylmethyl]-1h-indole
12/11/2008WO2008150217A1 2-amino-5, 5-diaryl-imidazol-4-one analogs for the inhibition of beta-secretase
12/11/2008WO2008150118A2 Novel amide derivative for inhibiting the growth of cancer cells
12/11/2008WO2008149382A1 Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application
12/11/2008WO2008149379A2 Novel compounds
12/11/2008WO2008149191A1 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions
12/11/2008WO2008149152A1 Novel process
12/11/2008WO2008148867A2 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases
12/11/2008WO2008148836A1 Compounds which potentiate ampa receptor and uses thereof in medicine
12/11/2008WO2008148832A1 Compounds which potentiate ampa receptor and uses therof in medicine
12/11/2008WO2008148688A1 Prolinamide-tetrazole derivatives as nk3 receptor antagonists
12/11/2008WO2008148359A1 The therapeutic uses of imidazol-5-carboxylic acid derivatives
12/11/2008WO2008148302A1 Arene connected polyamine macroring derivatives, preparation methods and pharmaceutical uses thereof
12/11/2008WO2008119825A3 Imidazolidine carboxamide derivatives as p2x7 modulators
12/11/2008WO2008109181A3 Metalloprotease inhibitors containing a heterocyclic moiety
12/11/2008WO2008103693A3 Chemical linkers with single amino acids and conjugates thereof
12/11/2008WO2008016522A3 Hiv reverse transcriptase inhibitors
12/11/2008WO2008014249A3 Improved preparations of 2 -substituted pyrrolo [2, 3-b] pyrazine ( 4, 7 -diazaindole ) compounds
12/11/2008WO2007089462A3 Piperidine and piperazine derivatives
12/11/2008US20080306258 Cyclopropane compounds and pharmaceutical use thereof
12/11/2008US20080306129 Benzimidazoles useful as modulators of ion channels
12/11/2008US20080306096 Quinazoline Derivatives, Process for Their Preparation and Their Use as Anti-Cancer Agents
12/11/2008US20080306091 2-Amino-5-[3-(2fluoropyridin-3-yl)phenyl]-3methyl-5-[3-methyl-1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl]-3,5-dihydro-4H-imidazol-4-one; Alzheimer's disease, cognitive impairment, Down's Syndrome, senile dementia, cerebral amyloid angiopathy, neurofibrillary tangles, beta -amyloid deposits
12/11/2008US20080306089 Prolinamide-tetrazole derivatives as nk3 receptor antagonists
12/11/2008US20080306087 1-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-4-(2-nitro-phenylmethanesulfonyl)-piperazine; acylation or sulfonamidation of the piperazine ring; psychological disorders, Parkinson's, Alzheimer's, Huntington's Diseases; antidepressants, entiepileptics
12/11/2008US20080306086 for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD); 2-{4-[(2S,4S)-1-benzyl-4-(2,4-difluoro-benzylamino)-pyrrolidine-2-carbonyl]-piperazin-1-yl}-benzonitrile
12/11/2008US20080306067 Modulators of Chemokine Receptor Activity
1 ... 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 ... 626